世界の感染症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Infectious Disease Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12383 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、感染症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染症治療の種類別市場規模（治療薬、ワクチン）、用途別市場規模（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・感染症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis AG、Gilead、GlaxoSmithKline plc、Janssen Pharmaceutical Inc.、F. Hoffmann-La Roche Ltd.、BioCryst Pharmaceuticals Inc.、Merck & Co. Inc.、Boehringer Ingelheim GmbH ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：治療薬、ワクチン ・用途別分析2016年-2026年：HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他 ・感染症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・感染症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・感染症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・感染症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・感染症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Infectious Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infectious Disease Therapeutics size is estimated to be USD 54160 million in 2026 from USD 47050 million in 2020, with a change XX% between 2020 and 2021. The global Infectious Disease Therapeutics market size is expected to grow at a CAGR of 3.6% for the next five years.

Market segmentation
Infectious Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Drugs
Vaccines

Market segment by Application, can be divided into
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others

Market segment by players, this report covers
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Infectious Disease Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Infectious Disease Therapeutics, with revenue, gross margin and global market share of Infectious Disease Therapeutics from 2019 to 2021.
Chapter 3, the Infectious Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Infectious Disease Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Infectious Disease Therapeutics research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Infectious Disease Therapeutics
1.2 Classification of Infectious Disease Therapeutics by Type
1.2.1 Overview: Global Infectious Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Infectious Disease Therapeutics Revenue Market Share by Type in 2020
1.2.3 Drugs
1.2.4 Vaccines
1.3 Global Infectious Disease Therapeutics Market by Application
1.3.1 Overview: Global Infectious Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 HIV/AIDS
1.3.3 Influenza
1.3.4 Hepatitis
1.3.5 Malaria
1.3.6 Tuberculosis
1.3.7 Others
1.4 Global Infectious Disease Therapeutics Market Size & Forecast
1.5 Global Infectious Disease Therapeutics Market Size and Forecast by Region
1.5.1 Global Infectious Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Infectious Disease Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Infectious Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Infectious Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Infectious Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Infectious Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Infectious Disease Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infectious Disease Therapeutics Market Drivers
1.6.2 Infectious Disease Therapeutics Market Restraints
1.6.3 Infectious Disease Therapeutics Trends Analysis
2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Infectious Disease Therapeutics Product and Solutions
2.1.4 Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Gilead
2.2.1 Gilead Details
2.2.2 Gilead Major Business
2.2.3 Gilead Infectious Disease Therapeutics Product and Solutions
2.2.4 Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Recent Developments and Future Plans
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business
2.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Product and Solutions
2.3.4 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.4 Janssen Pharmaceutical Inc.
2.4.1 Janssen Pharmaceutical Inc. Details
2.4.2 Janssen Pharmaceutical Inc. Major Business
2.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product and Solutions
2.4.4 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Janssen Pharmaceutical Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 BioCryst Pharmaceuticals Inc.
2.6.1 BioCryst Pharmaceuticals Inc. Details
2.6.2 BioCryst Pharmaceuticals Inc. Major Business
2.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product and Solutions
2.6.4 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BioCryst Pharmaceuticals Inc. Recent Developments and Future Plans
2.7 Merck & Co. Inc.
2.7.1 Merck & Co. Inc. Details
2.7.2 Merck & Co. Inc. Major Business
2.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Product and Solutions
2.7.4 Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck & Co. Inc. Recent Developments and Future Plans
2.8 Boehringer Ingelheim GmbH
2.8.1 Boehringer Ingelheim GmbH Details
2.8.2 Boehringer Ingelheim GmbH Major Business
2.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product and Solutions
2.8.4 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infectious Disease Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Infectious Disease Therapeutics Players Market Share
3.2.2 Top 10 Infectious Disease Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Infectious Disease Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infectious Disease Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Infectious Disease Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Infectious Disease Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Infectious Disease Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Infectious Disease Therapeutics Revenue by Type (2016-2026)
6.2 North America Infectious Disease Therapeutics Revenue by Application (2016-2026)
6.3 North America Infectious Disease Therapeutics Market Size by Country
6.3.1 North America Infectious Disease Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Infectious Disease Therapeutics Revenue by Type (2016-2026)
7.2 Europe Infectious Disease Therapeutics Revenue by Application (2016-2026)
7.3 Europe Infectious Disease Therapeutics Market Size by Country
7.3.1 Europe Infectious Disease Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infectious Disease Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Infectious Disease Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Infectious Disease Therapeutics Revenue by Region (2016-2026)
8.3.2 China Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Infectious Disease Therapeutics Revenue by Type (2016-2026)
9.2 South America Infectious Disease Therapeutics Revenue by Application (2016-2026)
9.3 South America Infectious Disease Therapeutics Market Size by Country
9.3.1 South America Infectious Disease Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infectious Disease Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Infectious Disease Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Infectious Disease Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Infectious Disease Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Infectious Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Infectious Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Infectious Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Infectious Disease Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Infectious Disease Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 7. Novartis AG Major Business
Table 8. Novartis AG Infectious Disease Therapeutics Product and Solutions
Table 9. Novartis AG Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Gilead Corporate Information, Head Office, and Major Competitors
Table 11. Gilead Major Business
Table 12. Gilead Infectious Disease Therapeutics Product and Solutions
Table 13. Gilead Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline plc Major Business
Table 16. GlaxoSmithKline plc Infectious Disease Therapeutics Product and Solutions
Table 17. GlaxoSmithKline plc Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Janssen Pharmaceutical Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Janssen Pharmaceutical Inc. Major Business
Table 20. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product and Solutions
Table 21. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Ltd. Major Business
Table 24. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product and Solutions
Table 25. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BioCryst Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 27. BioCryst Pharmaceuticals Inc. Major Business
Table 28. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product and Solutions
Table 29. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck & Co. Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Merck & Co. Inc. Major Business
Table 32. Merck & Co. Inc. Infectious Disease Therapeutics Product and Solutions
Table 33. Merck & Co. Inc. Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim GmbH Major Business
Table 36. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product and Solutions
Table 37. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Infectious Disease Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 39. Global Infectious Disease Therapeutics Revenue Share by Players (2019-2021)
Table 40. Breakdown of Infectious Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Infectious Disease Therapeutics Players Head Office, Products and Services Provided
Table 42. Infectious Disease Therapeutics Mergers & Acquisitions in the Past Five Years
Table 43. Infectious Disease Therapeutics New Entrants and Expansion Plans
Table 44. Global Infectious Disease Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 45. Global Infectious Disease Therapeutics Revenue Share by Type (2016-2021)
Table 46. Global Infectious Disease Therapeutics Revenue Forecast by Type (2021-2026)
Table 47. Global Infectious Disease Therapeutics Revenue by Application (2016-2021)
Table 48. Global Infectious Disease Therapeutics Revenue Forecast by Application (2021-2026)
Table 49. North America Infectious Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Infectious Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Infectious Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Infectious Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Infectious Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Infectious Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Infectious Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Infectious Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Infectious Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Infectious Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Infectious Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Infectious Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Infectious Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Infectious Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Infectious Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Infectious Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Infectious Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Infectious Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Infectious Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Infectious Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Infectious Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Infectious Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Infectious Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Infectious Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Infectious Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Infectious Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Infectious Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Infectious Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Infectious Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Infectious Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Infectious Disease Therapeutics Picture
Figure 2. Global Infectious Disease Therapeutics Revenue Market Share by Type in 2020
Figure 3. Drugs
Figure 4. Vaccines
Figure 5. Infectious Disease Therapeutics Revenue Market Share by Application in 2020
Figure 6. HIV/AIDS Picture
Figure 7. Influenza Picture
Figure 8. Hepatitis Picture
Figure 9. Malaria Picture
Figure 10. Tuberculosis Picture
Figure 11. Others Picture
Figure 12. Global Infectious Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Infectious Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Infectious Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 15. Global Infectious Disease Therapeutics Revenue Market Share by Region in 2020
Figure 16. North America Infectious Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Infectious Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Infectious Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Infectious Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Infectious Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Infectious Disease Therapeutics Market Drivers
Figure 22. Infectious Disease Therapeutics Market Restraints
Figure 23. Infectious Disease Therapeutics Market Trends
Figure 24. Novartis AG Recent Developments and Future Plans
Figure 25. Gilead Recent Developments and Future Plans
Figure 26. GlaxoSmithKline plc Recent Developments and Future Plans
Figure 27. Janssen Pharmaceutical Inc. Recent Developments and Future Plans
Figure 28. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Figure 29. BioCryst Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 30. Merck & Co. Inc. Recent Developments and Future Plans
Figure 31. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 32. Global Infectious Disease Therapeutics Revenue Share by Players in 2020
Figure 33. Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Infectious Disease Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Infectious Disease Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Infectious Disease Therapeutics Revenue Share by Type in 2020
Figure 38. Global Infectious Disease Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Infectious Disease Therapeutics Revenue Share by Application in 2020
Figure 40. Global Infectious Disease Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Infectious Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Infectious Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Infectious Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Infectious Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Infectious Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Infectious Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Infectious Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Infectious Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Infectious Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Infectious Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Infectious Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Infectious Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Infectious Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Infectious Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Infectious Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Infectious Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---